News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

Millions of people are living with Alzheimer's disease, a progressive, irreversible brain disorder that causes cognitive decline, confusion, memory loss, and many other symptoms. The Alzheimer's Assoc ...

Data from the Evoke trials suggests that GLP-1 drugs that treat type 2 diabetes do not have a significant effect on Alzheimer ...

The actor’s National Geographic documentary shows the power of memory and social connection in supporting his father’s ...

When you’re helping an aging parent manage doctors’ appointments, medications, or even the activities of daily life, you don’t need any reminders about the struggles of Alzheimer’s disease. You’re ...

Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of ...

Rutgers neuroscientist Peng Jiang and his neuroscience colleague Mengmeng Jin have made a discovery they say could reshape ...

Choose a calm moment, listen first and give the person time to share how they feel. Here are some other tips on how to help a ...

New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...

Novo Nordisk (NVO) fell nearly 10% in U.S. premarket trading on Monday after the Danish drugmaker said a pill version of ...

In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.